Charles River Laboratories International, Inc. (CRL)
199.48
-2.50
(-1.24%)
USD |
NYSE |
Dec 31, 16:00
199.52
+0.04
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Cash from Investing (Quarterly): -33.70M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Johnson & Johnson | -542.00M |
| Eli Lilly & Co. | -2.983B |
| Thermo Fisher Scientific, Inc. | -4.123B |
| IQVIA Holdings, Inc. | -550.00M |
| Medpace Holdings, Inc. | -10.66M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 213.83M |
| Cash from Financing (Quarterly) | -152.62M |
| Free Cash Flow | 543.67M |
| Free Cash Flow Per Share (Quarterly) | 3.606 |
| Free Cash Flow to Equity (Quarterly) | 335.94M |
| Free Cash Flow to Firm (Quarterly) | 194.43M |
| Free Cash Flow Yield | 5.43% |